Intel (INTC) 10-Q 24 Apr 20 2020 Q1 Quarterly report Financial data

Cover Page Cover Page

Cover Page Cover Page shares in Millions	3 Months Ended
	Mar. 28, 2020shares
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Mar. 28, 2020
Entity File Number	000-06217
Entity Registrant Name	INTEL CORPORATION
Entity Central Index Key	0000050863
Current Fiscal Year End Date	--12-26
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q1
Amendment Flag	false
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	94-1672743
Entity Address, Address Line One	2200 Mission College Boulevard,
Entity Address, City or Town	Santa Clara,
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95054-1549
City Area Code	(408)
Local Phone Number	765-8080
Title of 12(b) Security	Common stock, $0.001 par value
Trading Symbol	INTC
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding	4,234

Consolidated Condensed Statemen

Consolidated Condensed Statements of Income - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 28, 2020	Mar. 30, 2019
Income Statement [Abstract]
Net revenue	$ 19,828	$ 16,061
Cost of sales	7,812	6,972
Gross margin	12,016	9,089
Research and development	3,275	3,332
Marketing, general and administrative	1,541	1,583
Restructuring and other charges	162	0
Operating expenses	4,978	4,915
Operating income	7,038	4,174
Gains (losses) on equity investments, net	(111)	434
Interest and other, net	(313)	(61)
Income before taxes	6,614	4,547
Provision for taxes	953	573
Net income	$ 5,661	$ 3,974
Earnings per share - Basic (in dollars per share)	$ 1.33	$ 0.88
Earnings per share - Diluted (in dollars per share)	$ 1.31	$ 0.87
Weighted average shares of common stock outstanding:
Basic (shares)	4,266	4,492
Diluted (shares)	4,312	4,564

Consolidated Condensed Statem_2

Consolidated Condensed Statements of Comprehensive Income - USD ($) $ in Millions	3 Months Ended
	Mar. 28, 2020	Mar. 30, 2019
Statement of Comprehensive Income [Abstract]
Net income	$ 5,661	$ 3,974
Changes in other comprehensive income, net of tax:
Net unrealized holding gains (losses) on derivatives	(268)	102
Actuarial valuation and other pension benefits (expenses), net	12	9
Translation adjustments and other	(5)	50
Other comprehensive income (loss)	(261)	161
Total comprehensive income	$ 5,400	$ 4,135

Consolidated Condensed Balance

Consolidated Condensed Balance Sheets - USD ($) $ in Millions	Mar. 28, 2020	Dec. 28, 2019
Current assets:
Cash and cash equivalents	$ 11,380	$ 4,194
Short-term investments	1,296	1,082
Trading assets	8,127	7,847
Accounts receivable	8,455	7,659
Inventories	9,246	8,744
Other current assets	2,997	1,713
Total current assets	41,501	31,239
Property, plant and equipment, net of accumulated depreciation of $75,686 ($73,321 as of December 28, 2019)	56,770	55,386
Equity Investments	3,880	3,967
Other long-term investments	2,943	3,276
Goodwill	26,276	26,276
Identified intangible assets, net	10,429	10,827
Other long-term assets	5,911	5,553
Total assets	147,710	136,524
Current liabilities:
Short-term debt	3,464	3,693
Accounts payable	4,638	4,128
Accrued compensation and benefits	2,358	3,853
Other accrued liabilities	13,435	10,636
Total current liabilities	23,895	22,310
Debt	36,455	25,308
Contract Liabilities	1,353	1,368
Income taxes payable, non-current	4,651	4,919
Deferred income taxes	2,027	2,044
Other long-term liabilities	2,975	2,916
Contingencies (Note 12)
Temporary equity	0	155
Stockholders’ equity:
Preferred stock	0	0
Common stock and capital in excess of par value, 4,234 issued and outstanding (4,290 issued and outstanding as of December 28, 2019)	25,251	25,261
Accumulated other comprehensive income (loss)	(1,541)	(1,280)
Retained earnings	52,644	53,523
Total stockholders’ equity	76,354	77,504
Total liabilities, temporary equity, and stockholders’ equity	$ 147,710	$ 136,524

Consolidated Condensed Balanc_2

Consolidated Condensed Balance Sheets (Parenthetical) - USD ($) shares in Millions, $ in Millions	Mar. 28, 2020	Dec. 28, 2019
Assets
Accumulated depreciation	$ 75,686	$ 73,321
Stockholders’ equity:
Common stock, shares issued	4,234	4,290
Common stock, shares outstanding	4,234	4,290

Consolidated Condensed Statem_3

Consolidated Condensed Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended
	Mar. 28, 2020	Mar. 30, 2019
Statement of Cash Flows [Abstract]
Cash and cash equivalents, beginning of period	$ 4,194	$ 3,019
Cash flows provided by (used for) operating activities:
Net income	5,661	3,974
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	2,623	2,229
Share-based compensation	449	389
Amortization of intangibles	427	396
(Gains) losses on equity investments, net	134	(274)
Changes in assets and liabilities:
Accounts receivable	(796)	(235)
Inventories	(548)	(512)
Accounts payable	117	196
Accrued compensation and benefits	(1,500)	(1,620)
Prepaid supply agreements	(87)	(228)
Income taxes	753	440
Other assets and liabilities	(1,075)	204
Total adjustments	497	985
Net cash provided by operating activities	6,158	4,959
Cash flows provided by (used for) investing activities:
Additions to property, plant and equipment	(3,268)	(3,321)
Purchases of available-for-sale debt investments	(513)	(872)
Maturities and sales of available-for-sale debt investments	625	948
Purchases of trading assets	(3,897)	(1,869)
Maturities and sales of trading assets	3,660	1,554
Sales of equity investments	20	1,077
Other investing	(363)	(239)
Net cash used for investing activities	(3,736)	(2,722)
Cash flows provided by (used for) financing activities:
Increase (decrease) in short-term debt, net	0	1,682
Issuance of long-term debt, net of issuance costs	10,247	135
Repayment of debt and debt conversion	(1,075)	(861)
Proceeds from sales of common stock through employee equity incentive plans	503	290
Repurchase of common stock	(4,229)	(2,530)
Payment of dividends to stockholders	(1,408)	(1,414)
Other financing	726	596
Net cash provided by (used for) financing activities	4,764	(2,102)
Net increase (decrease) in cash and cash equivalents	7,186	135
Cash and cash equivalents, end of period	11,380	3,154
Supplemental disclosures of noncash investing activities and cash flow information:
Acquisition of property, plant, and equipment included in accounts payable and accrued liabilities	2,294	2,259
Interest, net of capitalized interest	67	109
Income taxes, net of refunds	$ 211	$ 125

Consolidated Statements of Stoc

Consolidated Statements of Stockholders' Equity Statement - USD ($) shares in Millions, $ in Millions	Total	Common Stock and Capital in Excess of Par Value	Accumulated Other Comprehensive Income (Loss)	Retained Earnings
Total stockholders' equity, beginning at Dec. 29, 2018	$ 74,563	$ 25,365	$ (974)	$ 50,172
Common stock, shares outstanding, beginning (in shares) at Dec. 29, 2018		4,516
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	3,974			3,974
Other comprehensive income (loss)	161		161
Employee equity incentive plans and other	372	$ 372
Employee equity incentive plans (in shares)		11
Share-based compensation	389	$ 389
Non-controlling interest	145	145
Repurchase of common stock	(592)	(592)
Repurchase of common stock	(2,450)	$ (278)		(2,172)
Repurchase of common stock (in shares)		(49)
Restricted stock unit withholdings	(72)	$ (55)		(17)
Restricted stock unit withholdings (in shares)		(1)
Cash dividends declared	(2,829)			(2,829)
Total stockholders' equity, ending at Mar. 30, 2019	73,661	$ 25,346	(813)	49,128
Common stock, shares outstanding, ending (in shares) at Mar. 30, 2019		4,477
Total stockholders' equity, beginning at Dec. 28, 2019	$ 77,504	$ 25,261	(1,280)	53,523
Common stock, shares outstanding, beginning (in shares) at Dec. 28, 2019	4,290	4,290
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	$ 5,661
Other comprehensive income (loss)	(261)		(261)
Employee equity incentive plans and other	620	$ 620
Employee equity incentive plans (in shares)		17
Share-based compensation	449	$ 449
Non-controlling interest	155	155
Repurchase of common stock	(750)	(750)
Repurchase of common stock	(4,109)	$ (420)		(3,689)
Repurchase of common stock (in shares)		(71)
Restricted stock unit withholdings	(96)	$ (64)		(32)
Restricted stock unit withholdings (in shares)		(2)
Cash dividends declared	(2,819)			(2,819)
Total stockholders' equity, ending at Mar. 28, 2020	$ 76,354	$ 25,251	$ (1,541)	$ 52,644
Common stock, shares outstanding, ending (in shares) at Mar. 28, 2020	4,234	4,234

Consolidated Statements of St_2

Consolidated Statements of Stockholders' Equity Statements of Stockholders' Equity (Parenthetical) - $ / shares	3 Months Ended
	Mar. 28, 2020	Mar. 30, 2019
Retained Earnings
Common Stock, Dividends, Per Share, Declared	$ 0.66	$ 0.63

Basis of Presentation

Basis of Presentation	3 Months Ended
	Mar. 28, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation [Text Block]	NOTE 1 : BASIS OF PRESENTATION We prepared our interim Consolidated Condensed Financial Statements that accompany these notes in conformity with U.S. GAAP, consistent in all material respects with those applied in our Form 10-K for the fiscal year ended December 28, 2019 . We have made estimates and judgments affecting the amounts reported in our Consolidated Condensed Financial Statements and the accompanying notes. The inputs into our judgments and estimates consider the economic implications of COVID-19 on our critical and significant accounting estimates. The actual results that we experience may differ materially from our estimates. The interim financial information is unaudited, and reflects all normal adjustments that are, in our opinion, necessary to provide a fair statement of results for the interim periods presented. This report should be read in conjunction with the Consolidated Financial Statements in our 2019 Form 10-K where we include additional information about our policies and the methods and assumptions used in our estimates.

Operating Segments

Operating Segments	3 Months Ended
	Mar. 28, 2020
Segment Reporting [Abstract]
Operating Segments [Text Block]	NOTE 2 : OPERATING SEGMENTS We manage our business through the following operating segments: • DCG • IOTG • Mobileye • NSG • PSG • CCG We derive a substantial majority of our revenue from platform products, which are our principal products and considered as one class of product. We offer platform products that incorporate various components and technologies, including a microprocessor and chipset, a stand-alone SoC, or a multichip package. Platform products are used in various form factors across our DCG, IOTG, and CCG operating segments. Our non-platform, or adjacent products, can be combined with platform products to form comprehensive platform solutions to meet customer needs. DCG and CCG are our reportable operating segments. IOTG, Mobileye, NSG, and PSG do not meet the quantitative thresholds to qualify as reportable operating segments; however, we have elected to disclose the results of these non-reportable operating segments. Our Internet of Things portfolio, presented as Internet of Things, is comprised of IOTG and Mobileye operating segments. We have an “all other” category that includes revenue, expenses, and charges such as: • results of operations from non-reportable segments not otherwise presented; • historical results of operations from divested businesses; • results of operations of start-up businesses that support our initiatives, including our foundry business; • amounts included within restructuring and other charges; • a portion of employee benefits, compensation, and other expenses not allocated to the operating segments; and • acquisition-related costs, including amortization and any impairment of acquisition-related intangibles and goodwill. The CODM, who is our CEO, does not evaluate operating segments using discrete asset information. Operating segments do not record inter-segment revenue. We do not allocate gains and losses from equity investments, interest and other income, or taxes to operating segments. Although the CODM uses operating income to evaluate the segments, operating costs included in one segment may benefit other segments. Except for these differences, the accounting policies for segment reporting are the same as for Intel as a whole. Net revenue and operating income (loss) for each period were as follows: Three Months Ended (In Millions) Mar 28, Mar 30, Net revenue: Data Center Group Platform $ 6,427 $ 4,482 Adjacent 566 420 6,993 4,902 Internet of Things IOTG 883 910 Mobileye 254 209 1,137 1,119 Non-Volatile Memory Solutions Group 1,338 915 Programmable Solutions Group 519 486 Client Computing Group Platform 8,712 7,824 Adjacent 1,063 762 9,775 8,586 All other 66 53 Total net revenue $ 19,828 $ 16,061 Operating income (loss): Data Center Group $ 3,492 $ 1,841 Internet of Things IOTG 243 251 Mobileye 88 68 331 319 Non-Volatile Memory Solutions Group (66 ) (297 ) Programmable Solutions Group 97 89 Client Computing Group 4,225 3,072 All other (1,041 ) (850 ) Total operating income $ 7,038 $ 4,174 Disaggregated net revenue for each period was as follows: Three Months Ended (In Millions) Mar 28, Mar 30, Platform revenue DCG platform $ 6,427 $ 4,482 IOTG platform 795 825 CCG Desktop platform 2,840 2,886 CCG Notebook platform 5,857 4,926 CCG other platform 1 15 12 15,934 13,131 Adjacent revenue 2 3,894 2,930 Total revenue $ 19,828 $ 16,061 1 Includes our tablet and service provider revenue. 2 Includes all of our non-platform products for DCG, IOTG, and CCG such as modem, Ethernet, and silicon photonics, as well as Mobileye, NSG, and PSG products. Planned Divestiture of our Home Gateway Platform Division

Earnings Per Share

Earnings Per Share	3 Months Ended
	Mar. 28, 2020
Earnings Per Share [Abstract]
Earnings Per Share [Text Block]	NOTE 3 : EARNINGS PER SHARE We computed basic earnings per share of common stock based on the weighted average number of shares of common stock outstanding during the period. We computed diluted earnings per share of common stock based on the weighted average number of shares of common stock outstanding plus potentially dilutive shares of common stock outstanding during the period. Three Months Ended (In Millions, Except Per Share Amounts) Mar 28, Mar 30, Net income available to common stockholders $ 5,661 $ 3,974 Weighted average shares of common stock outstanding—basic 4,266 4,492 Dilutive effect of employee equity incentive plans 46 53 Dilutive effect of convertible debt — 19 Weighted average shares of common stock outstanding—diluted 4,312 4,564 Earnings per share—basic $ 1.33 $ 0.88 Earnings per share—diluted $ 1.31 $ 0.87 Potentially dilutive shares of common stock from employee equity incentive plans are determined by applying the treasury stock method to the assumed exercise of outstanding stock options, the assumed vesting of outstanding RSUs, and the assumed issuance of common stock under the stock purchase plan. In January 2020, we fully redeemed the remaining principal of our 2009 Debentures. We included our 2009 Debentures in the calculation of diluted earnings per share of common stock in 2019 by applying the treasury stock method because the average market price was above the conversion price. Securities which would have been anti-dilutive are insignificant and are excluded from the computation of diluted earnings per share in all periods presented.

Contract Liabilities

Contract Liabilities	3 Months Ended
	Mar. 28, 2020
Revenue from Contract with Customer [Abstract]
Contract Liabilities [Text Block]	NOTE 4 : CONTRACT LIABILITIES (In Millions) Mar 28, Dec 28, Prepaid supply agreements $ 1,718 $ 1,805 Other 271 236 Total contract liabilities $ 1,989 $ 2,041 Contract liabilities are primarily related to prepayments received from customers on long-term prepaid supply agreements toward future NSG product delivery. The short-term portion of contract liabilities is reported on the Consolidated Condensed Balance Sheets within other accrued liabilities. The following table shows the changes in contract liability balances relating to long-term prepaid supply agreements during the first three months of 2020 : (In Millions) Prepaid supply agreements balance as of December 28, 2019 $ 1,805 Prepayments utilized (87 ) Prepaid supply agreements balance as of March 28, 2020 $ 1,718 If new long-term prepaid supply agreements are entered into and performance obligations are negotiated, this component of the contract liability balance will increase, and as customers purchase product and utilize their prepaid balances, the balance will decrease. The timing and amount of future anticipated revenues from these agreements may vary from our expectations due to changes in supply, demand, and market pricing.

Other Financial Statement Detai

Other Financial Statement Details	3 Months Ended
	Mar. 28, 2020
Other Financial Statement Details [Abstract]
Other Financial Statement Details [Text Block]	NOTE 5 : OTHER FINANCIAL STATEMENT DETAILS INVENTORIES (In Millions) Mar 28, Dec 28, Raw materials $ 877 $ 840 Work in process 6,654 6,225 Finished goods 1,715 1,679 Total inventories $ 9,246 $ 8,744 INTEREST AND OTHER, NET The components of interest and other, net for each period were as follows: Three Months Ended (In Millions) Mar 28, Mar 30, Interest income $ 93 $ 135 Interest expense (135 ) (138 ) Other, net (271 ) (58 ) Total interest and other, net $ (313 ) $ (61 ) Interest expense in the preceding table is net of $83 million of interest capitalized in the first three months of 2020 ( $125 million in the first three months of 2019 ).

Restructuring and Other Charges

Restructuring and Other Charges	3 Months Ended
	Mar. 28, 2020
Restructuring and Related Activities [Abstract]
Restructuring and Other Charges	NOTE 6 : RESTRUCTURING AND OTHER CHARGES A restructuring program was approved in the first quarter of 2020 to further align our workforce with our continuing investments in the business and execute the planned divestiture of Home Gateway Platform , a division of CCG. We expect these actions to be substantially complete in the third quarter of 2020. Restructuring and other charges by type for the period were as follows: Three Months Ended (In Millions) Mar 28, Employee severance and benefit arrangements $ 105 Asset impairment and other charges 57 Total restructuring and other charges $ 162

Investments

Investments	3 Months Ended
	Mar. 28, 2020
Investments and Cash [Abstract]
Investments [Text Block]	NOTE 7 : INVESTMENTS DEBT INVESTMENTS Trading Assets Net losses related to trading assets still held at the reporting date were $231 million in the first three months of 2020 ( $16 million of net gains in the first three months of 2019 ). Net gains on the related derivatives were $100 million in the first three months of 2020 ( $2 million of net gains in the first three months of 2019 ). Available-for-Sale Debt Investments March 28, 2020 December 28, 2019 (In Millions) Adjusted Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Adjusted Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Corporate debt $ 3,656 $ 46 $ (9 ) $ 3,693 $ 2,914 $ 44 $ — $ 2,958 Financial institution 9,482 12 (2 ) 9,492 3,007 15 (1 ) 3,021 Government debt 748 11 (1 ) 758 560 4 — 564 Total available-for-sale debt investments $ 13,886 $ 69 $ (12 ) $ 13,943 $ 6,481 $ 63 $ (1 ) $ 6,543 Government debt includes instruments such as non-U.S. government bonds and U.S. agency securities. Financial institution instruments include instruments issued or managed by financial institutions in various forms such as commercial paper, fixed and floating rate bonds, money market fund deposits, and time deposits. Substantially all time deposits were issued by institutions outside the U.S. as of March 28, 2020 and December 28, 2019 . The fair value of available-for-sale debt investments, by contractual maturity, as of March 28, 2020 , was as follows: (In Millions) Fair Value Due in 1 year or less $ 3,443 Due in 1–2 years 1,589 Due in 2–5 years 1,354 Due after 5 years — Instruments not due at a single maturity date 7,557 Total $ 13,943 EQUITY INVESTMENTS (In Millions) Mar 28, Dec 28, Marketable equity securities $ 330 $ 450 Non-marketable equity securities 3,522 3,480 Equity method investments 28 37 Total $ 3,880 $ 3,967 We recognized $143 million of impairment charges on our non-marketable portfolio in the first three months of 2020 based on our assessment of the impact of recent public and private market volatility and tightening of liquidity. The components of gains (losses) on equity investments, net for each period were as follows: Three Months Ended (In Millions) Mar 28, Mar 30, Ongoing mark-to-market adjustments on marketable equity securities $ (103 ) $ 253 Observable price adjustments on non-marketable equity securities 79 8 Impairment charges (143 ) (23 ) Sale of equity investments and other ¹ 56 196 Total gains (losses) on equity investments, net $ (111 ) $ 434 1 Sale of equity investments and other includes realized gains (losses) on sales of non-marketable equity investments, our share of equity method investee gains (losses) and distributions, and initial fair value adjustments recorded upon a security becoming marketable. Gains and losses for our marketable and non-marketable equity securities during the period were as follows: Three Months Ended (In Millions) Mar 28, Mar 30, Net gains (losses) recognized during the period on equity securities $ (140 ) $ 263 Less: Net (gains) losses recognized during the period on equity securities sold during the period (7 ) (190 ) Unrealized gains (losses) recognized during the reporting period on equity securities still held at the reporting date $ (147 ) $ 73 IMFT IMFT was formed in 2006 by Micron Technology, Inc. (Micron) and Intel to jointly develop NAND flash memory and 3D XPoint™ technology products. As of March 30, 2019 , we had a carrying value of $1.5 billion in IMFT and owned a 49% interest in the unconsolidated variable interest entity. We sold our non-controlling interest in IMFT to Micron in October 2019. We will continue to purchase product manufactured by Micron at the IMFT facility under supply agreements, which include the next generation of 3DXpoint technology.

Borrowings

Borrowings	3 Months Ended
	Mar. 28, 2020
Debt Disclosure [Abstract]
Borrowings	NOTE 8 : BORROWINGS As of March 28, 2020, our short-term debt was $3.5 billion , primarily comprised of the current portion of our long-term debt ( $3.7 billion as of December 28, 2019). We have an ongoing authorization from our Board of Directors to borrow up to $10.0 billion under our commercial paper program. LONG-TERM DEBT Mar 28, Dec 28, (In Millions) Effective Interest Rate Amount Amount Floating-rate senior notes: Three-month LIBOR plus 0.08%, due May 2020 1.93 % $ 700 $ 700 Three-month LIBOR plus 0.35%, due May 2022 2.19 % 800 800 Fixed-rate senior notes: 1.85%, due May 2020 1.88 % 1,000 1,000 2.45%, due July 2020 2.47 % 1,750 1,750 1.70%, due May 2021 1.77 % 500 500 3.30%, due October 2021 2.96 % 2,000 2,000 2.35%, due May 2022 1.95 % 750 750 3.10%, due July 2022 2.68 % 1,000 1,000 4.00%, due December 2022¹ 3.61 % 325 382 2.70%, due December 2022 2.27 % 1,500 1,500 4.10%, due November 2023 3.20 % 400 400 2.88%, due May 2024 2.30 % 1,250 1,250 2.70%, due June 2024 2.12 % 600 600 3.40%, due March 2025 3.46 % 1,500 — 3.70%, due July 2025 3.81 % 2,250 2,250 2.60%, due May 2026 2.28 % 1,000 1,000 3.75%, due March 2027 3.80 % 1,000 — 3.15%, due May 2027 2.84 % 1,000 1,000 2.45%, due November 2029 2.45 % 2,000 1,250 3.90%, due March 2030 3.94 % 1,500 — 4.00%, due December 2032 2.82 % 750 750 4.60%, due March 2040 4.63 % 750 — 4.80%, due October 2041 3.75 % 802 802 4.25%, due December 2042 3.00 % 567 567 4.90%, due July 2045 3.78 % 772 772 4.10%, due May 2046 3.04 % 1,250 1,250 4.10%, due May 2047 3.00 % 1,000 1,000 4.10%, due August 2047 2.58 % 640 640 3.73%, due December 2047 3.30 % 1,967 1,967 3.25%, due November 2049 3.22 % 2,000 1,500 4.75%, due March 2050 4.77 % 2,250 — 3.10%, due February 2060 3.12 % 1,000 — 4.95%, due March 2060 5.02 % 1,000 — Oregon and Arizona bonds: 2.40%-2.70%, due December 2035 - 2040 2.49 % 423 423 5.00%, due March 2049 2.11 % 138 138 5.00%, due June 2049 2.13 % 438 438 Junior Subordinated Convertible Debentures: 3.25%, due August 2039 — — 372 Total Senior Notes and Other Borrowings 38,572 28,751 Unamortized Premium/Discount and Issuance Costs (379 ) (529 ) Hedge Accounting Fair Value Adjustments 1,726 781 Long-term debt 39,919 29,003 Current portion of long-term debt (3,464 ) (3,695 ) Total long-term debt $ 36,455 $ 25,308 1 To manage foreign currency risk associated with the Australian-dollar-denominated notes issued in 2015, we entered into currency interest rate swaps with an aggregate notional amount of $396 million , which effectively converted these notes to U.S.-dollar-denominated notes. For further discussion on our currency interest rate swaps, see " Note 11: Derivative Financial Instruments ." In November 2019, we issued a notice of redemption for the remaining $372 million of 2009 Debentures with a redemption date of January 9, 2020. During the fourth quarter of 2019, the closing stock price conversion right condition of the 2009 Debentures continued to be met and therefore the debentures were convertible at the option of the holders until January 6, 2020. All 2009 Debentures were either converted prior to January 6, 2020 or redeemed on the redemption date. In the first three months of 2020 , we issued a total of $10.3 billion aggregate principal amount of senior notes. We intend to use the net proceeds from the offering for general corporate purposes, which may include refinancing outstanding debt, funding for working capital and capital expenditures, and repurchasing shares of our common stock. Our senior floating rate notes pay interest quarterly and our senior fixed rate notes pay interest semiannually. We may redeem the fixed rate notes prior to their maturity at our option at specified redemption prices and subject to certain restrictions. The obligations under the notes rank equally in right of payment with all of our other existing and future senior unsecured indebtedness and effectively rank junior to all liabilities of our subsidiaries.

Fair Value

Fair Value	3 Months Ended
	Mar. 28, 2020
Fair Value Disclosures [Abstract]
Fair Value [Text Block]	NOTE 9 : FAIR VALUE ASSETS AND LIABILITIES MEASURED AND RECORDED AT FAIR VALUE ON A RECURRING BASIS March 28, 2020 December 28, 2019 Fair Value Measured and Recorded at Reporting Date Using Fair Value Measured and Recorded at Reporting Date Using (In Millions) Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Assets Cash equivalents: Corporate debt $ — $ 1,348 $ — $ 1,348 $ — $ 713 $ — $ 713 Financial institution instruments¹ 7,557 600 — 8,157 1,064 408 — 1,472 Government debt² — 199 — 199 — — — — Reverse repurchase agreements — 1,150 — 1,150 — 1,500 — 1,500 Short-term investments: Corporate debt — 493 — 493 — 347 — 347 Financial institution instruments¹ — 803 — 803 — 724 — 724 Government debt² — — — — — 11 — 11 Trading assets: Corporate debt — 2,850 — 2,850 — 2,848 — 2,848 Financial institution instruments¹ 78 2,020 — 2,098 87 1,578 — 1,665 Government debt² — 3,179 — 3,179 — 3,334 — 3,334 Other current assets: Derivative assets 5 372 — 377 50 230 — 280 Loans receivable³ — 339 — 339 — — — — Marketable equity securities 330 — — 330 450 — — 450 Other long-term investments: Corporate debt — 1,852 — 1,852 — 1,898 — 1,898 Financial institution instruments¹ — 532 — 532 — 825 — 825 Government debt² — 559 — 559 — 553 — 553 Other long-term assets: Derivative assets — 1,604 35 1,639 — 690 16 706 Loans receivable³ — 203 — 203 — 554 — 554 Total assets measured and recorded at fair value $ 7,970 $ 18,103 $ 35 $ 26,108 $ 1,651 $ 16,213 $ 16 $ 17,880 Liabilities Other accrued liabilities: Derivative liabilities $ 190 $ 614 $ — $ 804 $ 3 $ 287 $ — $ 290 Other long-term liabilities: Derivative liabilities — 106 — 106 — 13 — 13 Total liabilities measured and recorded at fair value $ 190 $ 720 $ — $ 910 $ 3 $ 300 $ — $ 303 1 Level 1 investments consist of money market funds. Level 2 investments consist primarily of commercial paper, certificates of deposit, time deposits, and notes and bonds issued by financial institutions. 2 Level 2 investments consist primarily of U.S. agency notes and non-U.S. government debt. 3 The fair value of our loans receivable for which we elected the fair value option did not significantly differ from the contractual principal balance based on the contractual currency. ASSETS MEASURED AND RECORDED AT FAIR VALUE ON A NON-RECURRING BASIS Our non-marketable equity securities, equity method investments, and certain non-financial assets, such as intangible assets and property, plant and equipment, are recorded at fair value only if an impairment or observable price adjustment is recognized in the current period. If an observable price adjustment or impairment is recognized on our non-marketable equity securities during the period, we classify these assets as Level 3 within the fair value hierarchy based on the nature of the fair value inputs. FINANCIAL INSTRUMENTS NOT RECORDED AT FAIR VALUE ON A RECURRING BASIS Financial instruments not recorded at fair value on a recurring basis include non-marketable equity securities and equity method investments that have not been remeasured or impaired in the current period, grants receivable, loans receivable, reverse repurchase agreements, and issued debt. As of March 28, 2020 , the aggregate carrying value of grants receivable, loans receivable, and reverse repurchase agreements was $534 million ( $543 million as of December 28, 2019 ). The estimated fair value of these financial instruments approximates their carrying value and is categorized as Level 2 within the fair value hierarchy based on the nature of the fair value inputs. As of March 28, 2020 , the fair value of our issued debt was $41.3 billion ( $30.6 billion as of December 28, 2019

Other Comprehensive Income (Los

Other Comprehensive Income (Loss)	3 Months Ended
	Mar. 28, 2020
Equity [Abstract]
Other Comprehensive Income (Loss) [Text Block]	NOTE 10 : OTHER COMPREHENSIVE INCOME (LOSS) The changes in accumulated other comprehensive income (loss) by component and related tax effects in the first three months of 2020 were as follows: (In Millions) Unrealized Holding Gains (Losses) on Derivatives Actuarial Valuation and Other Pension Expenses Translation Adjustments and Other Total Balance as of December 29, 2019 $ 54 $ (1,382 ) $ 48 $ (1,280 ) Other comprehensive income (loss) before reclassifications (373 ) 3 (6 ) (376 ) Amounts reclassified out of accumulated other comprehensive income (loss) 68 14 — 82 Tax effects 37 (5 ) 1 33 Other comprehensive income (loss) (268 ) 12 (5 ) (261 ) Balance as of March 28, 2020 $ (214 ) $ (1,370 ) $ 43 $ (1,541 ) We estimate that we will reclassify approximately $135 million (before taxes) of net derivative losses included in accumulated other comprehensive income (loss) into earnings within the next 12 months.

Derivative Financial Instrument

Derivative Financial Instruments	3 Months Ended
	Mar. 28, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments [Text Block]	NOTE 11 : DERIVATIVE FINANCIAL INSTRUMENTS VOLUME OF DERIVATIVE ACTIVITY Total gross notional amounts for outstanding derivatives (recorded at fair value) at the end of each period were as follows: (In Millions) Mar 28, Dec 28, Foreign currency contracts $ 27,039 $ 23,981 Interest rate contracts 13,859 14,302 Other 1,726 1,753 Total $ 42,624 $ 40,036 FAIR VALUE OF DERIVATIVE INSTRUMENTS March 28, 2020 December 28, 2019 (In Millions) Assets 1 Liabilities 2 Assets 1 Liabilities 2 Derivatives designated as hedging instruments: Foreign currency contracts 3 $ 10 $ 465 $ 56 $ 159 Interest rate contracts 1,635 — 690 9 Total derivatives designated as hedging instruments 1,645 465 746 168 Derivatives not designated as hedging instruments: Foreign currency contracts 3 362 135 179 78 Interest rate contracts 4 120 11 54 Equity contracts 5 190 50 3 Total derivatives not designated as hedging instruments 371 445 240 135 Total derivatives $ 2,016 $ 910 $ 986 $ 303 1 Derivative assets are recorded as other assets, current and non-current. 2 Derivative liabilities are recorded as other liabilities, current and non-current. 3 The majority of these instruments mature within 12 months. AMOUNTS OFFSET IN THE CONSOLIDATED CONDENSED BALANCE SHEETS The gross amounts of our derivative instruments and reverse repurchase agreements subject to master netting arrangements with various counterparties, and cash and non-cash collateral posted under such agreements at the end of each period were as follows: March 28, 2020 Gross Amounts Not Offset in the Balance Sheet (In Millions) Gross Amounts Recognized Gross Amounts Offset in the Balance Sheet Net Amounts Presented in the Balance Sheet Financial Instruments Cash and Non-Cash Collateral Received or Pledged Net Amount Assets: Derivative assets subject to master netting arrangements $ 2,005 $ — $ 2,005 $ (457 ) $ (1,513 ) $ 35 Reverse repurchase agreements 1,500 — 1,500 — (1,418 ) 82 Total assets $ 3,505 $ — $ 3,505 $ (457 ) $ (2,931 ) $ 117 Liabilities: Derivative liabilities subject to master netting arrangements $ 865 $ — $ 865 $ (457 ) $ (221 ) $ 187 Total liabilities $ 865 $ — $ 865 $ (457 ) $ (221 ) $ 187 December 28, 2019 Gross Amounts Not Offset in the Balance Sheet (In Millions) Gross Amounts Recognized Gross Amounts Offset in the Balance Sheet Net Amounts Presented in the Balance Sheet Financial Instruments Cash and Non-Cash Collateral Received or Pledged Net Amount Assets: Derivative assets subject to master netting arrangements $ 974 $ — $ 974 $ (144 ) $ (808 ) $ 22 Reverse repurchase agreements 1,850 — 1,850 — (1,850 ) — Total assets $ 2,824 $ — $ 2,824 $ (144 ) $ (2,658 ) $ 22 Liabilities: Derivative liabilities subject to master netting arrangements $ 262 $ — $ 262 $ (144 ) $ (72 ) $ 46 Total liabilities $ 262 $ — $ 262 $ (144 ) $ (72 ) $ 46 We obtain and secure available collateral from counterparties against obligations, including securities lending transactions and reverse repurchase agreements, when we deem it appropriate . DERIVATIVES IN CASH FLOW HEDGING RELATIONSHIPS The before-tax net gains or losses attributed to cash flow hedges, recognized in other comprehensive income (loss), were $373 million net losses in the first three months of 2020 ( $29 million net gains in the first three months of 2019 ). Substantially all of our cash flow hedges were foreign currency contracts for all periods presented. During the first three months of 2020 and 2019 , the amounts excluded from effectiveness testing were insignificant . DERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS The effects of derivative instruments designated as fair value hedges, recognized in interest and other, net for each period were as follows: Gains (Losses) Recognized in Consolidated Condensed Statements of Income on Derivatives Three Months Ended (In Millions) Mar 28, Mar 30, Interest rate contracts $ 954 $ 485 Hedged items (954 ) (485 ) Total $ — $ — The amounts recorded on the Consolidated Condensed Balance Sheets related to cumulative basis adjustments for fair value hedges for each period were as follows: Line Item in the Consolidated Condensed Balance Sheet in Which the Hedged Item is Included Carrying Amount of the Hedged Item Asset/(Liabilities) Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount Assets/(Liabilities) (In Millions) Mar 28, Dec 28, Mar 28, Dec 28, Long-term debt $ (13,632 ) $ (12,678 ) $ (1,635 ) $ (681 ) The total notional amount of pay variable and receive fixed interest rate swaps was $12.0 billion as of March 28, 2020 and as of December 28, 2019 . DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS The effects of derivative instruments not designated as hedging instruments on the Consolidated Condensed Statements of Income for each period were as follows: Three Months Ended (In Millions) Location of Gains (Losses) Recognized in Income on Derivatives Mar 28, Mar 30, Foreign currency contracts Interest and other, net $ 154 $ 57 Interest rate contracts Interest and other, net (77 ) (14 ) Other Various (268 ) 146 Total $ (191 ) $ 189

Contingencies

Contingencies	3 Months Ended
	Mar. 28, 2020
Commitments and Contingencies Disclosure [Abstract]
Contingencies [Text Block]	NOTE 12 : CONTINGENCIES LEGAL PROCEEDINGS We are a party to various legal proceedings, including those noted in this section. Although management at present believes that the ultimate outcome of these proceedings, individually and in the aggregate, will not materially harm our financial position, results of operations, cash flows, or overall trends, legal proceedings and related government investigations are subject to inherent uncertainties, and unfavorable rulings or other events could occur. Unfavorable resolutions could include substantial monetary damages. In addition, in matters for which injunctive relief or other conduct remedies are sought, unfavorable resolutions could include an injunction or other order prohibiting us from selling one or more products at all or in particular ways, precluding particular business practices, or requiring other remedies. An unfavorable outcome may result in a material adverse impact on our business, results of operations, financial position, and overall trends. We might also conclude that settling one or more such matters is in the best interests of our stockholders, employees, and customers, and any such settlement could include substantial payments. Except as specifically described below, we have not concluded that settlement of any of the legal proceedings noted in this section is appropriate at this time. European Commission Competition Matter In 2001, the EC commenced an investigation regarding claims by Advanced Micro Devices, Inc. (AMD) that we used unfair business practices to persuade customers to buy our microprocessors. We received numerous requests for information and documents from the EC and we responded to each of those requests. The EC issued a Statement of Objections in July 2007 and held a hearing on that Statement in March 2008. The EC issued a Supplemental Statement of Objections in July 2008. In May 2009, the EC issued a decision finding that we had violated Article 82 of the EC Treaty and Article 54 of the European Economic Area Agreement. In general, the EC found that we violated Article 82 (later renumbered as Article 102 by a new treaty) by offering alleged "conditional rebates and payments" that required our customers to purchase all or most of their x86 microprocessors from us. The EC also found that we violated Article 82 by making alleged "payments to prevent sales of specific rival products." The EC imposed a fine in the amount of €1.1 billion ( $1.4 billion as of May 2009), which we subsequently paid during the third quarter of 2009, and ordered us to "immediately bring to an end the infringement referred to in" the EC decision. The EC decision contained no specific direction on whether or how we should modify our business practices. Instead, the decision stated that we should "cease and desist" from further conduct that, in the EC's opinion, would violate applicable law. We took steps, which are subject to the EC's ongoing review, to comply with that decision pending appeal. We had discussions with the EC to better understand the decision and to explain changes to our business practices. We appealed the EC decision to the Court of First Instance (which has been renamed the General Court) in July 2009. The hearing of our appeal took place in July 2012. In June 2014, the General Court rejected our appeal in its entirety. In August 2014, we filed an appeal with the European Court of Justice. In November 2014, Intervener Association for Competitive Technologies filed comments in support of Intel’s grounds of appeal. The EC and interveners filed briefs in November 2014, we filed a reply in February 2015, and the EC filed a rejoinder in April 2015. The Court of Justice held oral argument in June 2016. In October 2016, Advocate General Wahl, an advisor to the Court of Justice, issued a non-binding advisory opinion that favored Intel on a number of grounds. The Court of Justice issued its decision in September 2017, setting aside the judgment of the General Court and sending the case back to the General Court to examine whether the rebates at issue were capable of restricting competition. The General Court has appointed a panel of five judges to consider our appeal of the EC’s 2009 decision in light of the Court of Justice’s clarifications of the law. In November 2017, the parties filed initial “Observations” about the Court of Justice’s decision and the appeal and were invited by the General Court to offer supplemental comments to each other’s “Observations,” which the parties submitted in March 2018. Responses to other questions posed by the General Court were filed in May and June 2018. The General Court heard oral argument in March 2020. Pending the final decision in this matter, the fine paid by Intel has been placed by the EC in commercial bank accounts where it accrues interest. Litigation Related to Security Vulnerabilities In June 2017, a Google research team notified us and other companies that it had identified security vulnerabilities (now commonly referred to as “Spectre” and “Meltdown”) that affect many types of microprocessors, including our products. As is standard when findings like these are presented, we worked together with other companies in the industry to verify the research and develop and validate software and firmware updates for impacted technologies. On January 3, 2018, information on the security vulnerabilities was publicly reported, before software and firmware updates to address the vulnerabilities were made widely available. Numerous lawsuits relating to the Spectre and Meltdown security vulnerabilities, as well as another variant of these vulnerabilities (“Foreshadow”) that has since been identified, have been filed against Intel and, in certain cases, our current and former executives and directors, in U.S. federal and state courts and in certain courts in other countries. As of April 22, 2020 , consumer class action lawsuits relating to certain security vulnerabilities publicly disclosed in 2018 were pending in the U.S., Canada, and Israel. The plaintiffs, who purport to represent various classes of purchasers of our products, generally claim to have been harmed by Intel's actions and/or omissions in connection with the security vulnerabilities and assert a variety of common law and statutory claims seeking monetary damages and equitable relief. In the U.S., numerous individual class action suits filed in various jurisdictions were consolidated in April 2018 for all pretrial proceedings in the U.S. District Court for the District of Oregon. In March 2020, the court granted Intel's motion to dismiss the complaint in that consolidated action, but granted plaintiffs leave to file an amended complaint. In Canada, in one case pending in the Superior Court of Justice of Ontario, an initial status conference has not yet been scheduled. In a second case pending in the Superior Court of Justice of Quebec, the court has stayed the case until April 2020. In Israel, both consumer class action lawsuits were filed in the District Court of Haifa. In the first case, the District Court denied the parties' joint motion to stay filed in January 2019, but to date has deferred Intel's deadline to respond to the complaint in view of Intel's pending motion to dismiss in the consolidated proceeding in the U.S. Intel filed a motion to stay the second case pending resolution of the consolidated proceeding in the U.S., and a hearing on that motion has been scheduled for May 2020. Additional lawsuits and claims may be asserted seeking monetary damages or other related relief. We dispute the pending claims described above and intend to defend those lawsuits vigorously. Given the procedural posture and the nature of those cases, including that the pending proceedings are in the early stages, that alleged damages have not been specified, that uncertainty exists as to the likelihood of a class or classes being certified or the ultimate size of any class or classes if certified, and that there are significant factual and legal issues to be resolved, we are unable to make a reasonable estimate of the potential loss or range of losses, if any, that might arise from those matters. In addition to these lawsuits, Intel stockholders filed multiple shareholder derivative lawsuits since January 2018 against certain current and former members of our Board of Directors and certain current and former officers, alleging that the defendants breached their duties to Intel in connection with the disclosure of the security vulnerabilities and the failure to take action in relation to alleged insider trading. The complaints sought to recover damages from the defendants on behalf of Intel. Some of the derivative actions were filed in the U.S. District Court for the Northern District of California and were consolidated, and the others were filed in the Superior Court of the State of California in San Mateo County and were consolidated. The federal court granted defendants' motion to dismiss the consolidated complaint in the federal action in August 2018 on the ground that plaintiffs failed to plead facts sufficient to show they were excused from making a pre-lawsuit demand on the Board. The federal court granted plaintiffs leave to amend their complaint, but subsequently dismissed the cases without prejudice in January 2019 at plaintiffs' request. In August 2018, the California Superior Court granted defendants' motion to dismiss the consolidated complaint in the state court action on the ground that plaintiffs failed to plead facts sufficient to show they were excused from making a pre-lawsuit demand on the Board, but granted plaintiffs leave to amend. The court subsequently granted defendants' motion to dismiss plaintiffs' first, second, and third amended complaints, on the same ground, and in March 2020 granted defendants' motion to dismiss plaintiffs' third amended complaint without granting plaintiffs leave to amend. Plaintiffs filed a motion for reconsideration of the court's final order of dismissal, which is scheduled for hearing in June 2020. Institute of Microelectronics, Chinese Academy of Sciences v. Intel China, Ltd., et al. In February 2018, the Institute of Microelectronics of the Chinese Academy of Sciences (IMECAS) sued Intel China, Ltd., Dell China, Ltd. (Dell) and Beijing JingDong Century Information Technology, Ltd. (JD) for patent infringement in the Beijing High Court. IMECAS alleges that Intel’s Core series processors infringe Chinese patent CN 102956457 (’457 Patent). The complaint demands an injunction and damages of at least RMB 200,000,000 plus the cost of litigation. A trial date is not yet set. In March 2018, Dell tendered indemnity to Intel, which Intel granted in April 2018. JD also tendered indemnity to Intel, which Intel granted in October 2018. In March 2018, Intel filed an invalidation request on the ‘457 patent with the Chinese Patent Reexamination Board (PRB). The PRB held an oral hearing in September 2018 and in February 2019 upheld the validity of the challenged claims. In January 2020, Intel filed a second invalidation request on the ‘457 patent with the PRB. In September 2018 and March 2019, Intel filed petitions with the United States Patent & Trademark Office (USPTO) requesting institution of inter partes review (IPR) of U.S. Patent No. 9,070,719, the U.S. counterpart to the ‘457 patent. The USPTO denied institution of Intel’s petitions in March and October 2019, respectively. In April 2019, Intel filed a request for rehearing and a petition for Precedential Opinion Panel (POP) in the USPTO to challenge the denial of its first IPR petition, and in November 2019 Intel filed a request for rehearing on the second IPR petition. In January 2020, the USPTO denied the rehearing and petition on the first IPR petition. In October 2019, IMECAS filed second and third lawsuits, in the Beijing IP Court, alleging infringement of Chinese Patent No. CN 102386226 (‘226 Patent) based on the manufacturing and sale of Intel’s Core i3 microprocessors. Defendants in the second case are Lenovo (Beijing) Co., Ltd. (Lenovo) and Beijing Jiayun Huitong Technology Development Co. Ltd. (BJHT). Defendants in the third case are Intel Corp., Intel China Co., Ltd., the Intel China Beijing Branch, Beijing Digital China Co., Ltd. (Digital China), and JD. Both complaints demand injunctions plus litigation costs and reserve the right to claim damages in unspecified amounts. No proceedings have occurred or are yet scheduled in these lawsuits. In December 2019, Lenovo tendered indemnity to Intel, which Intel granted in March 2020. Given the procedural posture and the nature of these cases, the unspecified nature and extent of damages claimed by IMECAS, and uncertainty regarding the availability of injunctive relief under applicable law, we are unable to make a reasonable estimate of the potential loss or range of losses, if any, arising from these matters. We dispute IMECAS’s claims and intend to vigorously defend against them.

Operating Segments (Tables)

Operating Segments (Tables)	3 Months Ended
	Mar. 28, 2020
Segment Reporting [Abstract]
Schedule of Segment Reporting Information, by Segment [Table Text Block]	Net revenue and operating income (loss) for each period were as follows: Three Months Ended (In Millions) Mar 28, Mar 30, Net revenue: Data Center Group Platform $ 6,427 $ 4,482 Adjacent 566 420 6,993 4,902 Internet of Things IOTG 883 910 Mobileye 254 209 1,137 1,119 Non-Volatile Memory Solutions Group 1,338 915 Programmable Solutions Group 519 486 Client Computing Group Platform 8,712 7,824 Adjacent 1,063 762 9,775 8,586 All other 66 53 Total net revenue $ 19,828 $ 16,061 Operating income (loss): Data Center Group $ 3,492 $ 1,841 Internet of Things IOTG 243 251 Mobileye 88 68 331 319 Non-Volatile Memory Solutions Group (66 ) (297 ) Programmable Solutions Group 97 89 Client Computing Group 4,225 3,072 All other (1,041 ) (850 ) Total operating income $ 7,038 $ 4,174
Revenue from External Customers by Products and Services [Table Text Block]	Disaggregated net revenue for each period was as follows: Three Months Ended (In Millions) Mar 28, Mar 30, Platform revenue DCG platform $ 6,427 $ 4,482 IOTG platform 795 825 CCG Desktop platform 2,840 2,886 CCG Notebook platform 5,857 4,926 CCG other platform 1 15 12 15,934 13,131 Adjacent revenue 2 3,894 2,930 Total revenue $ 19,828 $ 16,061 1 Includes our tablet and service provider revenue. 2 Includes all of our non-platform products for DCG, IOTG, and CCG such as modem, Ethernet, and silicon photonics, as well as Mobileye, NSG, and PSG products.

Earnings Per Share (Tables)

Earnings Per Share (Tables)	3 Months Ended
	Mar. 28, 2020
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Three Months Ended (In Millions, Except Per Share Amounts) Mar 28, Mar 30, Net income available to common stockholders $ 5,661 $ 3,974 Weighted average shares of common stock outstanding—basic 4,266 4,492 Dilutive effect of employee equity incentive plans 46 53 Dilutive effect of convertible debt — 19 Weighted average shares of common stock outstanding—diluted 4,312 4,564 Earnings per share—basic $ 1.33 $ 0.88 Earnings per share—diluted $ 1.31 $ 0.87

Contract Liabilities (Tables)

Contract Liabilities (Tables)	3 Months Ended
	Mar. 28, 2020
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue [Table Text Block]	(In Millions) Mar 28, Dec 28, Prepaid supply agreements $ 1,718 $ 1,805 Other 271 236 Total contract liabilities $ 1,989 $ 2,041
Contract with Customer, Asset and Liability [Table Text Block]	The following table shows the changes in contract liability balances relating to long-term prepaid supply agreements during the first three months of 2020 : (In Millions) Prepaid supply agreements balance as of December 28, 2019 $ 1,805 Prepayments utilized (87 ) Prepaid supply agreements balance as of March 28, 2020 $ 1,718

Other Financial Statement Det_2

Other Financial Statement Details (Tables)	3 Months Ended
	Mar. 28, 2020
Other Financial Statement Details [Abstract]
Schedule of Inventory, Current [Table Text Block]	(In Millions) Mar 28, Dec 28, Raw materials $ 877 $ 840 Work in process 6,654 6,225 Finished goods 1,715 1,679 Total inventories $ 9,246 $ 8,744
Interest and Other, Net [Table Text Block]	The components of interest and other, net for each period were as follows: Three Months Ended (In Millions) Mar 28, Mar 30, Interest income $ 93 $ 135 Interest expense (135 ) (138 ) Other, net (271 ) (58 ) Total interest and other, net $ (313 ) $ (61 )

Restructuring and Other Charg_2

Restructuring and Other Charges (Tables)	3 Months Ended
	Mar. 28, 2020
Restructuring and Related Activities [Abstract]
Schedule of Restructuring and Other Charges	Restructuring and other charges by type for the period were as follows: Three Months Ended (In Millions) Mar 28, Employee severance and benefit arrangements $ 105 Asset impairment and other charges 57 Total restructuring and other charges $ 162

Investments (Tables)

Investments (Tables)	3 Months Ended
	Mar. 28, 2020
Investments and Cash [Abstract]
Schedule of Available-for-sale Securities Reconciliation [Table Text Block]	March 28, 2020 December 28, 2019 (In Millions) Adjusted Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Adjusted Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Corporate debt $ 3,656 $ 46 $ (9 ) $ 3,693 $ 2,914 $ 44 $ — $ 2,958 Financial institution 9,482 12 (2 ) 9,492 3,007 15 (1 ) 3,021 Government debt 748 11 (1 ) 758 560 4 — 564 Total available-for-sale debt investments $ 13,886 $ 69 $ (12 ) $ 13,943 $ 6,481 $ 63 $ (1 ) $ 6,543
Investments Classified by Contractual Maturity Date [Table Text Block]	The fair value of available-for-sale debt investments, by contractual maturity, as of March 28, 2020 , was as follows: (In Millions) Fair Value Due in 1 year or less $ 3,443 Due in 1–2 years 1,589 Due in 2–5 years 1,354 Due after 5 years — Instruments not due at a single maturity date 7,557 Total $ 13,943
Investment [Table Text Block]	(In Millions) Mar 28, Dec 28, Marketable equity securities $ 330 $ 450 Non-marketable equity securities 3,522 3,480 Equity method investments 28 37 Total $ 3,880 $ 3,967
Gain (Loss) on Securities [Table Text Block]	The components of gains (losses) on equity investments, net for each period were as follows: Three Months Ended (In Millions) Mar 28, Mar 30, Ongoing mark-to-market adjustments on marketable equity securities $ (103 ) $ 253 Observable price adjustments on non-marketable equity securities 79 8 Impairment charges (143 ) (23 ) Sale of equity investments and other ¹ 56 196 Total gains (losses) on equity investments, net $ (111 ) $ 434 1 Sale of equity investments and other includes realized gains (losses) on sales of non-marketable equity investments, our share of equity method investee gains (losses) and distributions, and initial fair value adjustments recorded upon a security becoming marketable. Gains and losses for our marketable and non-marketable equity securities during the period were as follows: Three Months Ended (In Millions) Mar 28, Mar 30, Net gains (losses) recognized during the period on equity securities $ (140 ) $ 263 Less: Net (gains) losses recognized during the period on equity securities sold during the period (7 ) (190 ) Unrealized gains (losses) recognized during the reporting period on equity securities still held at the reporting date $ (147 ) $ 73

Borrowings (Tables)

Borrowings (Tables)	3 Months Ended
	Mar. 28, 2020
Debt Disclosure [Abstract]
Schedule of Long-term Debt Instruments	LONG-TERM DEBT Mar 28, Dec 28, (In Millions) Effective Interest Rate Amount Amount Floating-rate senior notes: Three-month LIBOR plus 0.08%, due May 2020 1.93 % $ 700 $ 700 Three-month LIBOR plus 0.35%, due May 2022 2.19 % 800 800 Fixed-rate senior notes: 1.85%, due May 2020 1.88 % 1,000 1,000 2.45%, due July 2020 2.47 % 1,750 1,750 1.70%, due May 2021 1.77 % 500 500 3.30%, due October 2021 2.96 % 2,000 2,000 2.35%, due May 2022 1.95 % 750 750 3.10%, due July 2022 2.68 % 1,000 1,000 4.00%, due December 2022¹ 3.61 % 325 382 2.70%, due December 2022 2.27 % 1,500 1,500 4.10%, due November 2023 3.20 % 400 400 2.88%, due May 2024 2.30 % 1,250 1,250 2.70%, due June 2024 2.12 % 600 600 3.40%, due March 2025 3.46 % 1,500 — 3.70%, due July 2025 3.81 % 2,250 2,250 2.60%, due May 2026 2.28 % 1,000 1,000 3.75%, due March 2027 3.80 % 1,000 — 3.15%, due May 2027 2.84 % 1,000 1,000 2.45%, due November 2029 2.45 % 2,000 1,250 3.90%, due March 2030 3.94 % 1,500 — 4.00%, due December 2032 2.82 % 750 750 4.60%, due March 2040 4.63 % 750 — 4.80%, due October 2041 3.75 % 802 802 4.25%, due December 2042 3.00 % 567 567 4.90%, due July 2045 3.78 % 772 772 4.10%, due May 2046 3.04 % 1,250 1,250 4.10%, due May 2047 3.00 % 1,000 1,000 4.10%, due August 2047 2.58 % 640 640 3.73%, due December 2047 3.30 % 1,967 1,967 3.25%, due November 2049 3.22 % 2,000 1,500 4.75%, due March 2050 4.77 % 2,250 — 3.10%, due February 2060 3.12 % 1,000 — 4.95%, due March 2060 5.02 % 1,000 — Oregon and Arizona bonds: 2.40%-2.70%, due December 2035 - 2040 2.49 % 423 423 5.00%, due March 2049 2.11 % 138 138 5.00%, due June 2049 2.13 % 438 438 Junior Subordinated Convertible Debentures: 3.25%, due August 2039 — — 372 Total Senior Notes and Other Borrowings 38,572 28,751 Unamortized Premium/Discount and Issuance Costs (379 ) (529 ) Hedge Accounting Fair Value Adjustments 1,726 781 Long-term debt 39,919 29,003 Current portion of long-term debt (3,464 ) (3,695 ) Total long-term debt $ 36,455 $ 25,308 1 To manage foreign currency risk associated with the Australian-dollar-denominated notes issued in 2015, we entered into currency interest rate swaps with an aggregate notional amount of $396 million , which effectively converted these notes to U.S.-dollar-denominated notes. For further discussion on our currency interest rate swaps, see " Note 11: Derivative Financial Instruments ."

Fair Value (Tables)

Fair Value (Tables)	3 Months Ended
	Mar. 28, 2020
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	ASSETS AND LIABILITIES MEASURED AND RECORDED AT FAIR VALUE ON A RECURRING BASIS March 28, 2020 December 28, 2019 Fair Value Measured and Recorded at Reporting Date Using Fair Value Measured and Recorded at Reporting Date Using (In Millions) Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Assets Cash equivalents: Corporate debt $ — $ 1,348 $ — $ 1,348 $ — $ 713 $ — $ 713 Financial institution instruments¹ 7,557 600 — 8,157 1,064 408 — 1,472 Government debt² — 199 — 199 — — — — Reverse repurchase agreements — 1,150 — 1,150 — 1,500 — 1,500 Short-term investments: Corporate debt — 493 — 493 — 347 — 347 Financial institution instruments¹ — 803 — 803 — 724 — 724 Government debt² — — — — — 11 — 11 Trading assets: Corporate debt — 2,850 — 2,850 — 2,848 — 2,848 Financial institution instruments¹ 78 2,020 — 2,098 87 1,578 — 1,665 Government debt² — 3,179 — 3,179 — 3,334 — 3,334 Other current assets: Derivative assets 5 372 — 377 50 230 — 280 Loans receivable³ — 339 — 339 — — — — Marketable equity securities 330 — — 330 450 — — 450 Other long-term investments: Corporate debt — 1,852 — 1,852 — 1,898 — 1,898 Financial institution instruments¹ — 532 — 532 — 825 — 825 Government debt² — 559 — 559 — 553 — 553 Other long-term assets: Derivative assets — 1,604 35 1,639 — 690 16 706 Loans receivable³ — 203 — 203 — 554 — 554 Total assets measured and recorded at fair value $ 7,970 $ 18,103 $ 35 $ 26,108 $ 1,651 $ 16,213 $ 16 $ 17,880 Liabilities Other accrued liabilities: Derivative liabilities $ 190 $ 614 $ — $ 804 $ 3 $ 287 $ — $ 290 Other long-term liabilities: Derivative liabilities — 106 — 106 — 13 — 13 Total liabilities measured and recorded at fair value $ 190 $ 720 $ — $ 910 $ 3 $ 300 $ — $ 303 1 Level 1 investments consist of money market funds. Level 2 investments consist primarily of commercial paper, certificates of deposit, time deposits, and notes and bonds issued by financial institutions. 2 Level 2 investments consist primarily of U.S. agency notes and non-U.S. government debt. 3 The fair value of our loans receivable for which we elected the fair value option did not significantly differ from the contractual principal balance based on the contractual currency.

Other Comprehensive Income (L_2

Other Comprehensive Income (Loss) (Tables)	3 Months Ended
	Mar. 28, 2020
Equity [Abstract]
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]	The changes in accumulated other comprehensive income (loss) by component and related tax effects in the first three months of 2020 were as follows: (In Millions) Unrealized Holding Gains (Losses) on Derivatives Actuarial Valuation and Other Pension Expenses Translation Adjustments and Other Total Balance as of December 29, 2019 $ 54 $ (1,382 ) $ 48 $ (1,280 ) Other comprehensive income (loss) before reclassifications (373 ) 3 (6 ) (376 ) Amounts reclassified out of accumulated other comprehensive income (loss) 68 14 — 82 Tax effects 37 (5 ) 1 33 Other comprehensive income (loss) (268 ) 12 (5 ) (261 ) Balance as of March 28, 2020 $ (214 ) $ (1,370 ) $ 43 $ (1,541 )

Derivative Financial Instrume_2

Derivative Financial Instruments (Tables)	3 Months Ended
	Mar. 28, 2020
Derivative [Line Items]
Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]	Total gross notional amounts for outstanding derivatives (recorded at fair value) at the end of each period were as follows: (In Millions) Mar 28, Dec 28, Foreign currency contracts $ 27,039 $ 23,981 Interest rate contracts 13,859 14,302 Other 1,726 1,753 Total $ 42,624 $ 40,036
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]	The amounts recorded on the Consolidated Condensed Balance Sheets related to cumulative basis adjustments for fair value hedges for each period were as follows: Line Item in the Consolidated Condensed Balance Sheet in Which the Hedged Item is Included Carrying Amount of the Hedged Item Asset/(Liabilities) Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount Assets/(Liabilities) (In Millions) Mar 28, Dec 28, Mar 28, Dec 28, Long-term debt $ (13,632 ) $ (12,678 ) $ (1,635 ) $ (681 ) FAIR VALUE OF DERIVATIVE INSTRUMENTS March 28, 2020 December 28, 2019 (In Millions) Assets 1 Liabilities 2 Assets 1 Liabilities 2 Derivatives designated as hedging instruments: Foreign currency contracts 3 $ 10 $ 465 $ 56 $ 159 Interest rate contracts 1,635 — 690 9 Total derivatives designated as hedging instruments 1,645 465 746 168 Derivatives not designated as hedging instruments: Foreign currency contracts 3 362 135 179 78 Interest rate contracts 4 120 11 54 Equity contracts 5 190 50 3 Total derivatives not designated as hedging instruments 371 445 240 135 Total derivatives $ 2,016 $ 910 $ 986 $ 303 1 Derivative assets are recorded as other assets, current and non-current. 2 Derivative liabilities are recorded as other liabilities, current and non-current. 3 The majority of these instruments mature within 12 months.
Offsetting Assets [Table Text Block]	The gross amounts of our derivative instruments and reverse repurchase agreements subject to master netting arrangements with various counterparties, and cash and non-cash collateral posted under such agreements at the end of each period were as follows: March 28, 2020 Gross Amounts Not Offset in the Balance Sheet (In Millions) Gross Amounts Recognized Gross Amounts Offset in the Balance Sheet Net Amounts Presented in the Balance Sheet Financial Instruments Cash and Non-Cash Collateral Received or Pledged Net Amount Assets: Derivative assets subject to master netting arrangements $ 2,005 $ — $ 2,005 $ (457 ) $ (1,513 ) $ 35 Reverse repurchase agreements 1,500 — 1,500 — (1,418 ) 82 Total assets $ 3,505 $ — $ 3,505 $ (457 ) $ (2,931 ) $ 117 Liabilities: Derivative liabilities subject to master netting arrangements $ 865 $ — $ 865 $ (457 ) $ (221 ) $ 187 Total liabilities $ 865 $ — $ 865 $ (457 ) $ (221 ) $ 187 December 28, 2019 Gross Amounts Not Offset in the Balance Sheet (In Millions) Gross Amounts Recognized Gross Amounts Offset in the Balance Sheet Net Amounts Presented in the Balance Sheet Financial Instruments Cash and Non-Cash Collateral Received or Pledged Net Amount Assets: Derivative assets subject to master netting arrangements $ 974 $ — $ 974 $ (144 ) $ (808 ) $ 22 Reverse repurchase agreements 1,850 — 1,850 — (1,850 ) — Total assets $ 2,824 $ — $ 2,824 $ (144 ) $ (2,658 ) $ 22 Liabilities: Derivative liabilities subject to master netting arrangements $ 262 $ — $ 262 $ (144 ) $ (72 ) $ 46 Total liabilities $ 262 $ — $ 262 $ (144 ) $ (72 ) $ 46
Offsetting Liabilities [Table Text Block]	The gross amounts of our derivative instruments and reverse repurchase agreements subject to master netting arrangements with various counterparties, and cash and non-cash collateral posted under such agreements at the end of each period were as follows: March 28, 2020 Gross Amounts Not Offset in the Balance Sheet (In Millions) Gross Amounts Recognized Gross Amounts Offset in the Balance Sheet Net Amounts Presented in the Balance Sheet Financial Instruments Cash and Non-Cash Collateral Received or Pledged Net Amount Assets: Derivative assets subject to master netting arrangements $ 2,005 $ — $ 2,005 $ (457 ) $ (1,513 ) $ 35 Reverse repurchase agreements 1,500 — 1,500 — (1,418 ) 82 Total assets $ 3,505 $ — $ 3,505 $ (457 ) $ (2,931 ) $ 117 Liabilities: Derivative liabilities subject to master netting arrangements $ 865 $ — $ 865 $ (457 ) $ (221 ) $ 187 Total liabilities $ 865 $ — $ 865 $ (457 ) $ (221 ) $ 187 December 28, 2019 Gross Amounts Not Offset in the Balance Sheet (In Millions) Gross Amounts Recognized Gross Amounts Offset in the Balance Sheet Net Amounts Presented in the Balance Sheet Financial Instruments Cash and Non-Cash Collateral Received or Pledged Net Amount Assets: Derivative assets subject to master netting arrangements $ 974 $ — $ 974 $ (144 ) $ (808 ) $ 22 Reverse repurchase agreements 1,850 — 1,850 — (1,850 ) — Total assets $ 2,824 $ — $ 2,824 $ (144 ) $ (2,658 ) $ 22 Liabilities: Derivative liabilities subject to master netting arrangements $ 262 $ — $ 262 $ (144 ) $ (72 ) $ 46 Total liabilities $ 262 $ — $ 262 $ (144 ) $ (72 ) $ 46
Not Designated as Hedging Instrument [Member]
Derivative [Line Items]
Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance [Table Text Block]	The effects of derivative instruments not designated as hedging instruments on the Consolidated Condensed Statements of Income for each period were as follows: Three Months Ended (In Millions) Location of Gains (Losses) Recognized in Income on Derivatives Mar 28, Mar 30, Foreign currency contracts Interest and other, net $ 154 $ 57 Interest rate contracts Interest and other, net (77 ) (14 ) Other Various (268 ) 146 Total $ (191 ) $ 189
Interest and other, net [Member] | Fair Value Hedging
Derivative [Line Items]
Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance [Table Text Block]	The effects of derivative instruments designated as fair value hedges, recognized in interest and other, net for each period were as follows: Gains (Losses) Recognized in Consolidated Condensed Statements of Income on Derivatives Three Months Ended (In Millions) Mar 28, Mar 30, Interest rate contracts $ 954 $ 485 Hedged items (954 ) (485 ) Total $ — $ —

Business Segments (Detail)

Business Segments (Detail) - USD ($) $ in Millions	3 Months Ended
	Mar. 28, 2020	Mar. 30, 2019
Segment Reporting Information [Line Items]
Net revenue	$ 19,828	$ 16,061
Operating Income (Loss)	7,038	4,174
Platform
Segment Reporting Information [Line Items]
Net revenue	15,934	13,131
Adjacent revenue
Segment Reporting Information [Line Items]
Net revenue	3,894	2,930
Internet of Things [Member]
Segment Reporting Information [Line Items]
Net revenue	1,137	1,119
Operating Income (Loss)	331	319
Client Computing Group [Member]
Segment Reporting Information [Line Items]
Net revenue	9,775	8,586
Operating Income (Loss)	4,225	3,072
Client Computing Group [Member] | Platform
Segment Reporting Information [Line Items]
Net revenue	8,712	7,824
Client Computing Group [Member] | Adjacent revenue
Segment Reporting Information [Line Items]
Net revenue	1,063	762
Data Center Group [Member]
Segment Reporting Information [Line Items]
Net revenue	6,993	4,902
Operating Income (Loss)	3,492	1,841
Data Center Group [Member] | Adjacent revenue
Segment Reporting Information [Line Items]
Net revenue	566	420
Internet of Things Group [Member]
Segment Reporting Information [Line Items]
Net revenue	883	910
Operating Income (Loss)	243	251
Mobileye [Member]
Segment Reporting Information [Line Items]
Net revenue	254	209
Operating Income (Loss)	88	68
Non-Volatile Memory Solutions Group [Member]
Segment Reporting Information [Line Items]
Net revenue	1,338	915
Operating Income (Loss)	(66)	(297)
Programmable Solutions Group [Member]
Segment Reporting Information [Line Items]
Net revenue	519	486
Operating Income (Loss)	97	89
All other [Member]
Segment Reporting Information [Line Items]
Net revenue	66	53
Operating Income (Loss)	$ (1,041)	$ (850)

Product Information (Detail)

Product Information (Detail) - USD ($) $ in Millions	3 Months Ended
	Mar. 28, 2020	Mar. 30, 2019
Revenue from External Customer [Line Items]
Net revenue	$ 19,828	$ 16,061
DCG platform
Revenue from External Customer [Line Items]
Net revenue	6,427	4,482
IOTG platform
Revenue from External Customer [Line Items]
Net revenue	795	825
CCG Desktop platform
Revenue from External Customer [Line Items]
Net revenue	2,840	2,886
CCG Notebook platform
Revenue from External Customer [Line Items]
Net revenue	5,857	4,926
Other platform
Revenue from External Customer [Line Items]
Net revenue	15	12
Platform
Revenue from External Customer [Line Items]
Net revenue	15,934	13,131
Adjacent revenue
Revenue from External Customer [Line Items]
Net revenue	$ 3,894	$ 2,930

Earnings Per Share (Detail)

Earnings Per Share (Detail) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended
	Mar. 28, 2020	Mar. 30, 2019
Earnings Per Share [Abstract]
Net income	$ 5,661	$ 3,974
Weighted average shares of common stock outstanding—basic	4,266	4,492
Dilutive effect of employee equity incentive plans (shares)	46	53
Dilutive effect of convertible debt (shares)	0	19
Weighted average shares of common stock outstanding—diluted	4,312	4,564
Earnings per share - Basic (in dollars per share)	$ 1.33	$ 0.88
Earnings per share - Diluted (in dollars per share)	$ 1.31	$ 0.87

Contract Liabilities (Details)

Contract Liabilities (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 28, 2020	Dec. 28, 2019
Capitalized Contract Cost [Line Items]
Contract with Customer, Liability	$ 1,989	$ 2,041
Prepaid Supply Agreements [Member]
Capitalized Contract Cost [Line Items]
Contract with Customer, Liability	1,718	1,805
Contract with Customer, Liability, Revenue Recognized	(87)
Software, Services and Other [Member]
Capitalized Contract Cost [Line Items]
Contract with Customer, Liability	$ 271	$ 236

Other Financial Statement Det_3

Other Financial Statement Details Inventories (Details) - USD ($) $ in Millions	Mar. 28, 2020	Dec. 28, 2019
Inventory, Net [Abstract]
Raw materials	$ 877	$ 840
Work in process	6,654	6,225
Finished goods	1,715	1,679
Total inventories	$ 9,246	$ 8,744

Other Financial Statement Det_4

Other Financial Statement Details Interest and Other, Net (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 28, 2020	Mar. 30, 2019
Other Nonoperating Income (Expense) [Abstract]
Interest income	$ 93	$ 135
Interest expense	(135)	(138)
Other, net	(271)	(58)
Total interest and other, net	(313)	(61)
Interest Costs Capitalized	$ 83	$ 125

Restructuring and Other Charg_3

Restructuring and Other Charges (Detail) - 2020 Restructuring Program [Member] $ in Millions	3 Months Ended
	Mar. 28, 2020USD ($)
Restructuring Cost and Reserve [Line Items]
Employee severance and benefit arrangements	$ 105
Asset impairment and other charges	57
Total restructuring and other charges	$ 162

Investments, Trading Assets (De

Investments, Trading Assets (Detail) - Debt Securities [Member] - USD ($) $ in Millions	3 Months Ended
	Mar. 28, 2020	Mar. 30, 2019
Schedule Of Trading Securities And Other Trading Assets [Line Items]
Debt Securities, Trading, Unrealized Gain (Loss)	$ (231)	$ 16
Unrealized Gain (Loss) on Derivatives	$ 100	$ 2

Investments, Available-for-Sale

Investments, Available-for-Sale Debt Investments (Detail) - USD ($) $ in Millions	Mar. 28, 2020	Dec. 28, 2019
Debt Securities, Available-for-sale [Line Items]
Adjusted Cost	$ 13,886	$ 6,481
Gross Unrealized Gains	69	63
Gross Unrealized Losses	(12)	(1)
Fair Value	13,943	6,543
Due in 1 year or less	3,443
Due in 1–2 years	1,589
Due in 2–5 years	1,354
Due after 5 years	0
Instruments not due at a single maturity date	7,557
Corporate Debt Securities [Member]
Debt Securities, Available-for-sale [Line Items]
Adjusted Cost	3,656	2,914
Gross Unrealized Gains	46	44
Gross Unrealized Losses	(9)	0
Fair Value	3,693	2,958
Fixed Income Securities [Member]
Debt Securities, Available-for-sale [Line Items]
Adjusted Cost	9,482	3,007
Gross Unrealized Gains	12	15
Gross Unrealized Losses	(2)	(1)
Fair Value	9,492	3,021
Government Debt [Member]
Debt Securities, Available-for-sale [Line Items]
Adjusted Cost	748	560
Gross Unrealized Gains	11	4
Gross Unrealized Losses	(1)	0
Fair Value	$ 758	$ 564

Investments, Equity Investments

Investments, Equity Investments (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 28, 2020	Mar. 30, 2019	Dec. 28, 2019
Schedule of Investments [Line Items]
Marketable Securities	$ 330		$ 450
Cost Method Investments	3,522		3,480
Equity Method Investments	28		37
Equity Investments	3,880		$ 3,967
Mark to market on marketable equity securities1	(103)	$ 253
Observable price adjustments on non-marketable	79	8
Impairments	(143)	(23)
Other Net Equity Investments	56	196
Gain (Loss) on Investments	(111)	434
Net gains (losses) recognized during the period on equity securities	(140)	263
Less: Net (gains) losses recognized during the period on equity securities sold during the period	(7)	(190)
Unrealized gains (losses) recognized during the reporting period on equity securities still held at the reporting date	$ (147)	73
IM Flash Technologies, LLC [Member]
Schedule of Investments [Line Items]
Equity Method Investments		$ 1,500

Investments, Equity Method Inve

Investments, Equity Method Investments (Detail) - USD ($) $ in Millions	Mar. 28, 2020	Dec. 28, 2019	Mar. 30, 2019
Schedule of Equity Method Investments [Line Items]
Carrying Value, equity method investments	$ 28	$ 37
Marketable Securities	$ 330	$ 450
IM Flash Technologies, LLC [Member]
Schedule of Equity Method Investments [Line Items]
Ownership Percentage			49.00%
Carrying Value, equity method investments			$ 1,500

Borrowings Borrowings, Narrativ

Borrowings Borrowings, Narrative (Details) - USD ($)	1 Months Ended
	Nov. 30, 2019	Mar. 28, 2020	Dec. 28, 2019
Debt Instrument [Line Items]
Short-term debt		$ 3,464,000,000	$ 3,695,000,000
Convertible debentures | 2009 Debentures
Debt Instrument [Line Items]
Redemption of debentures	$ 372,000,000
Senior Notes
Debt Instrument [Line Items]
Debt instrument, face amount		10,300,000,000
Commercial Paper
Debt Instrument [Line Items]
Authorization to borrow		$ 10,000,000,000

Borrowings, Long-term Debt (Det

Borrowings, Long-term Debt (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Mar. 28, 2020	Dec. 28, 2019
Debt Instrument [Line Items]
Amount	$ 38,572	$ 28,751
Unamortized Premium/Discount and Issuance Costs	(379)	(529)
Long-term debt	39,919	29,003
Current portion of long-term debt	(3,464)	(3,695)
Total long-term debt	36,455	25,308
Notional amount	42,624	40,036
Fair Value Hedging | Interest Rate Swap
Debt Instrument [Line Items]
Hedge Accounting Fair Value Adjustments	$ 1,726	781
Floating-rate senior notes: Three-month LIBOR plus 0.08%, due May 2020
Debt Instrument [Line Items]
Effective Interest Rate	1.93%
Amount	$ 700	700
Floating-rate senior notes: Three-month LIBOR plus 0.08%, due May 2020 | LIBOR
Debt Instrument [Line Items]
Variable rate	0.08%
Floating-rate senior notes: Three-month LIBOR plus 0.35%, due May 2022
Debt Instrument [Line Items]
Effective Interest Rate	2.19%
Amount	$ 800	800
Floating-rate senior notes: Three-month LIBOR plus 0.35%, due May 2022 | LIBOR
Debt Instrument [Line Items]
Variable rate	0.35%
1.85%, due May 2020
Debt Instrument [Line Items]
Interest rate	1.85%
Effective Interest Rate	1.88%
Amount	$ 1,000	1,000
2.45%, due July 2020
Debt Instrument [Line Items]
Interest rate	2.45%
Effective Interest Rate	2.47%
Amount	$ 1,750	1,750
1.70%, due May 2021
Debt Instrument [Line Items]
Interest rate	1.70%
Effective Interest Rate	1.77%
Amount	$ 500	500
3.30%, due October 2021
Debt Instrument [Line Items]
Interest rate	3.30%
Effective Interest Rate	2.96%
Amount	$ 2,000	2,000
2.35%, due May 2022
Debt Instrument [Line Items]
Interest rate	2.35%
Effective Interest Rate	1.95%
Amount	$ 750	750
3.10%, due July 2022
Debt Instrument [Line Items]
Interest rate	3.10%
Effective Interest Rate	2.68%
Amount	$ 1,000	1,000
4.00%, due December 2022¹
Debt Instrument [Line Items]
Interest rate	4.00%
Effective Interest Rate	3.61%
Amount	$ 325	382
4.00%, due December 2022¹ | Cross Currency Interest Rate Contract
Debt Instrument [Line Items]
Notional amount	$ 396
2.70%, due December 2022
Debt Instrument [Line Items]
Interest rate	2.70%
Effective Interest Rate	2.27%
Amount	$ 1,500	1,500
4.10%, due November 2023
Debt Instrument [Line Items]
Interest rate	4.10%
Effective Interest Rate	3.20%
Amount	$ 400	400
2.88%, due May 2024
Debt Instrument [Line Items]
Interest rate	2.88%
Effective Interest Rate	2.30%
Amount	$ 1,250	1,250
2.70%, due June 2024
Debt Instrument [Line Items]
Interest rate	2.70%
Effective Interest Rate	2.12%
Amount	$ 600	600
3.40%, due March 2025
Debt Instrument [Line Items]
Interest rate	3.40%
Effective Interest Rate	3.46%
Amount	$ 1,500	0
3.70%, due July 2025
Debt Instrument [Line Items]
Interest rate	3.70%
Effective Interest Rate	3.81%
Amount	$ 2,250	2,250
2.60%, due May 2026
Debt Instrument [Line Items]
Interest rate	2.60%
Effective Interest Rate	2.28%
Amount	$ 1,000	1,000
3.75%, due March 2027
Debt Instrument [Line Items]
Interest rate	3.75%
Effective Interest Rate	3.80%
Amount	$ 1,000	0
3.15%, due May 2027
Debt Instrument [Line Items]
Interest rate	3.15%
Effective Interest Rate	2.84%
Amount	$ 1,000	1,000
2.45%, due November 2029
Debt Instrument [Line Items]
Interest rate	2.45%
Effective Interest Rate	2.45%
Amount	$ 2,000	1,250
3.90%, due March 2030
Debt Instrument [Line Items]
Interest rate	3.90%
Effective Interest Rate	3.94%
Amount	$ 1,500	0
4.00%, due December 2032
Debt Instrument [Line Items]
Interest rate	4.00%
Effective Interest Rate	2.82%
Amount	$ 750	750
4.60%, due March 2040
Debt Instrument [Line Items]
Interest rate	4.60%
Effective Interest Rate	4.63%
Amount	$ 750	0
4.60%, due March 2040
Debt Instrument [Line Items]
Interest rate	4.80%
Effective Interest Rate	3.75%
Amount	$ 802	802
4.25%, due December 2042
Debt Instrument [Line Items]
Interest rate	4.25%
Effective Interest Rate	3.00%
Amount	$ 567	567
4.90%, due July 2045
Debt Instrument [Line Items]
Interest rate	4.90%
Effective Interest Rate	3.78%
Amount	$ 772	772
4.10%, due May 2046
Debt Instrument [Line Items]
Interest rate	4.10%
Effective Interest Rate	3.04%
Amount	$ 1,250	1,250
4.10%, due May 2047
Debt Instrument [Line Items]
Interest rate	4.10%
Effective Interest Rate	3.00%
Amount	$ 1,000	1,000
4.10%, due August 2047
Debt Instrument [Line Items]
Interest rate	4.10%
Effective Interest Rate	2.58%
Amount	$ 640	640
3.73%, due December 2047
Debt Instrument [Line Items]
Interest rate	3.73%
Effective Interest Rate	3.30%
Amount	$ 1,967	1,967
3.25%, due November 2049
Debt Instrument [Line Items]
Interest rate	3.25%
Effective Interest Rate	3.22%
Amount	$ 2,000	1,500
4.75%, due March 2050
Debt Instrument [Line Items]
Interest rate	4.75%
Effective Interest Rate	4.77%
Amount	$ 2,250	0
3.10%, due February 2060
Debt Instrument [Line Items]
Interest rate	3.10%
Effective Interest Rate	3.12%
Amount	$ 1,000	0
4.95%, due March 2060
Debt Instrument [Line Items]
Interest rate	4.95%
Effective Interest Rate	5.02%
Amount	$ 1,000	0
2.40%-2.70%, due December 2035 - 2040
Debt Instrument [Line Items]
Effective Interest Rate	2.49%
Amount	$ 423	423
2.40%-2.70%, due December 2035 - 2040 | Minimum
Debt Instrument [Line Items]
Interest rate	2.40%
2.40%-2.70%, due December 2035 - 2040 | Maximum
Debt Instrument [Line Items]
Interest rate	2.70%
5.00%, due March 2049
Debt Instrument [Line Items]
Interest rate	5.00%
Effective Interest Rate	2.11%
Amount	$ 138	138
5.00%, due June 2049
Debt Instrument [Line Items]
Interest rate	5.00%
Effective Interest Rate	2.13%
Amount	$ 438	438
3.25%, due August 2039
Debt Instrument [Line Items]
Interest rate	3.25%
Effective Interest Rate	0.00%
Junior Subordinated Convertible Debentures	$ 0	$ 372

Fair Value (Detail)

Fair Value (Detail) - USD ($) $ in Millions	Mar. 28, 2020	Dec. 28, 2019
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Reverse repurchase agreements	$ 1,500	$ 1,850
Trading assets, Fair Value Disclosure	8,127	7,847
Derivative assets, Fair Value Disclosure	2,005	974
Derivative liabilities, Fair Value Disclosure	865	262
Cost Method Investments	3,522	3,480
Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	26,108	17,880
Liabilities, Fair Value Disclosure	910	303
Fair Value, Nonrecurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Grants & loans Receivable, Reverse repurchase agreements, CV	534	543
Short-term and Long-term Debt, Fair Value	41,300	30,600
Corporate Debt Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets, Fair Value Disclosure	2,850	2,848
Fixed Income Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets, Fair Value Disclosure	2,098	1,665
Government Debt [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets, Fair Value Disclosure	3,179	3,334
Marketable Equity Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	330	450
Cash Equivalents [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Reverse repurchase agreements	1,150	1,500
Cash Equivalents [Member] | Corporate Debt Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	1,348	713
Cash Equivalents [Member] | Fixed Income Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	8,157	1,472
Cash Equivalents [Member] | Government Debt [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	199	0
Short-Term Investments [Member] | Corporate Debt Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	493	347
Short-Term Investments [Member] | Fixed Income Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	803	724
Short-Term Investments [Member] | Government Debt [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	11
Other Current Assets [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, Fair Value Disclosure	377	280
Loans receivable, Fair Value Disclosure	339	0
Other Long-Term Investments [Member] | Corporate Debt Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	1,852	1,898
Other Long-Term Investments [Member] | Fixed Income Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	532	825
Other Long-Term Investments [Member] | Government Debt [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	559	553
Other Long-Term Assets [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, Fair Value Disclosure	1,639	706
Loans receivable, Fair Value Disclosure	203	554
Other Accrued Liabilities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, Fair Value Disclosure	804	290
Other Long-Term Liabilities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, Fair Value Disclosure	106	13
Level 1 [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	7,970	1,651
Liabilities, Fair Value Disclosure	190	3
Level 1 [Member] | Corporate Debt Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets, Fair Value Disclosure	0	0
Level 1 [Member] | Fixed Income Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets, Fair Value Disclosure	78	87
Level 1 [Member] | Government Debt [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets, Fair Value Disclosure	0	0
Level 1 [Member] | Marketable Equity Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	330	450
Level 1 [Member] | Cash Equivalents [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Reverse repurchase agreements	0	0
Level 1 [Member] | Cash Equivalents [Member] | Corporate Debt Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 1 [Member] | Cash Equivalents [Member] | Fixed Income Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	7,557	1,064
Level 1 [Member] | Cash Equivalents [Member] | Government Debt [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 1 [Member] | Short-Term Investments [Member] | Corporate Debt Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 1 [Member] | Short-Term Investments [Member] | Fixed Income Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 1 [Member] | Short-Term Investments [Member] | Government Debt [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 1 [Member] | Other Current Assets [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, Fair Value Disclosure	5	50
Loans receivable, Fair Value Disclosure	0	0
Level 1 [Member] | Other Long-Term Investments [Member] | Corporate Debt Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 1 [Member] | Other Long-Term Investments [Member] | Fixed Income Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 1 [Member] | Other Long-Term Investments [Member] | Government Debt [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 1 [Member] | Other Long-Term Assets [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, Fair Value Disclosure	0	0
Loans receivable, Fair Value Disclosure	0	0
Level 1 [Member] | Other Accrued Liabilities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, Fair Value Disclosure	190	3
Level 1 [Member] | Other Long-Term Liabilities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, Fair Value Disclosure	0	0
Level 2 [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	18,103	16,213
Liabilities, Fair Value Disclosure	720	300
Level 2 [Member] | Corporate Debt Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets, Fair Value Disclosure	2,850	2,848
Level 2 [Member] | Fixed Income Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets, Fair Value Disclosure	2,020	1,578
Level 2 [Member] | Government Debt [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets, Fair Value Disclosure	3,179	3,334
Level 2 [Member] | Marketable Equity Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 2 [Member] | Cash Equivalents [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Reverse repurchase agreements	1,150	1,500
Level 2 [Member] | Cash Equivalents [Member] | Corporate Debt Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	1,348	713
Level 2 [Member] | Cash Equivalents [Member] | Fixed Income Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	600	408
Level 2 [Member] | Cash Equivalents [Member] | Government Debt [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	199	0
Level 2 [Member] | Short-Term Investments [Member] | Corporate Debt Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	493	347
Level 2 [Member] | Short-Term Investments [Member] | Fixed Income Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	803	724
Level 2 [Member] | Short-Term Investments [Member] | Government Debt [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	11
Level 2 [Member] | Other Current Assets [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, Fair Value Disclosure	372	230
Loans receivable, Fair Value Disclosure	339	0
Level 2 [Member] | Other Long-Term Investments [Member] | Corporate Debt Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	1,852	1,898
Level 2 [Member] | Other Long-Term Investments [Member] | Fixed Income Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	532	825
Level 2 [Member] | Other Long-Term Investments [Member] | Government Debt [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	559	553
Level 2 [Member] | Other Long-Term Assets [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, Fair Value Disclosure	1,604	690
Loans receivable, Fair Value Disclosure	203	554
Level 2 [Member] | Other Accrued Liabilities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, Fair Value Disclosure	614	287
Level 2 [Member] | Other Long-Term Liabilities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, Fair Value Disclosure	106	13
Level 3 [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	35	16
Liabilities, Fair Value Disclosure	0	0
Level 3 [Member] | Corporate Debt Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets, Fair Value Disclosure	0	0
Level 3 [Member] | Fixed Income Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets, Fair Value Disclosure	0	0
Level 3 [Member] | Government Debt [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets, Fair Value Disclosure	0	0
Level 3 [Member] | Marketable Equity Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 3 [Member] | Cash Equivalents [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Reverse repurchase agreements	0	0
Level 3 [Member] | Cash Equivalents [Member] | Corporate Debt Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 3 [Member] | Cash Equivalents [Member] | Fixed Income Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 3 [Member] | Cash Equivalents [Member] | Government Debt [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 3 [Member] | Short-Term Investments [Member] | Corporate Debt Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 3 [Member] | Short-Term Investments [Member] | Fixed Income Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 3 [Member] | Short-Term Investments [Member] | Government Debt [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 3 [Member] | Other Current Assets [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, Fair Value Disclosure	0	0
Loans receivable, Fair Value Disclosure	0	0
Level 3 [Member] | Other Long-Term Investments [Member] | Corporate Debt Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 3 [Member] | Other Long-Term Investments [Member] | Fixed Income Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 3 [Member] | Other Long-Term Investments [Member] | Government Debt [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Level 3 [Member] | Other Long-Term Assets [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, Fair Value Disclosure	35	16
Loans receivable, Fair Value Disclosure	0	0
Level 3 [Member] | Other Accrued Liabilities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, Fair Value Disclosure	0	0
Level 3 [Member] | Other Long-Term Liabilities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, Fair Value Disclosure	$ 0	$ 0

Other Comprehensive Income (L_3

Other Comprehensive Income (Loss), Accumulated Other Comprehensive Income (Loss) (Detail) - USD ($) $ in Millions	3 Months Ended
	Mar. 28, 2020	Mar. 30, 2019	Dec. 28, 2019
Accumulated Other Comprehensive Income (Loss) [Line Items]
Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months	$ (135)
Accumulated Other Comprehensive Income (Loss), Net of Tax	(1,541)		$ (1,280)
Other comprehensive income (loss)	(261)	$ 161
Unrealized holding gains (losses) on available-for-sale investments [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive income (loss)	(214)		54
Other comprehensive income (loss) before reclassifications	(373)
Amounts reclassified out of accumulated other comprehensive income (loss)	68
Tax effects	37
Other comprehensive income (loss)	(268)
Unrealized holding gains (losses) on derivatives [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive income (loss)	(1,370)		(1,382)
Other comprehensive income (loss) before reclassifications	3
Amounts reclassified out of accumulated other comprehensive income (loss)	14
Tax effects	(5)
Other comprehensive income (loss)	12
Actuarial gains (losses) [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive income (loss)	43		48
Other comprehensive income (loss) before reclassifications	(6)
Amounts reclassified out of accumulated other comprehensive income (loss)	0
Tax effects	1
Other comprehensive income (loss)	(5)
Foreign currency translation adjustment [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive income (loss)	(1,541)		$ (1,280)
Other comprehensive income (loss) before reclassifications	(376)
Amounts reclassified out of accumulated other comprehensive income (loss)	82
Tax effects	33
Other comprehensive income (loss)	$ (261)

Derivative Financial Instrume_3

Derivative Financial Instruments (Detail) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Mar. 28, 2020	Mar. 30, 2019	Dec. 28, 2019
Notional Disclosures [Abstract]
Notional amount	$ 42,624		$ 40,036
Offsetting Derivative Assets [Abstract]
Derivative Assets, Fair Value, Gross Amounts	2,005		974
Derivative Assets Subject to Master Netting Arrangements, Gross Amounts Offset in the Balance Sheet	0		0
Derivative Assets Subject to Master Netting Arrangements, Net Amount Presented in the Balance Sheet	2,005		974
Derivative Assets, Financial Instruments Not Offset in the Balance Sheet	(457)		(144)
Derivative Assets, Cash Collateral Not Offset in the Balance Sheet	(1,513)		(808)
Derivative Assets Subject to Master Netting Arrangements, Net Amount	35		22
Reverse Repurchase Agreements, Gross Amounts Recognized	1,500		1,850
Reverse Repurchase Agreements, Gross Amounts Offset In The Balance Sheet	0		0
Reverse Repurchase Agreements, Net Amount Presented in the Balance Sheet	1,500		1,850
Reverse Repurchase Agreements, Financial Instruments Not Offset in the Balance Sheet	0		0
Reverse Repurchase Agreements, Cash Collateral Not Offset in the Balance Sheet	(1,418)		(1,850)
Reverse Repurchase Agreements, Net Amount	82		0
Total Assets, Gross Amounts Recognized	3,505		2,824
Total Assets, Gross Amounts Offset in the Balance Sheet	0		0
Total Assets, Net Amounts Presented in the Balance Sheet	3,505		2,824
Total Assets, Financial Instruments, Not Offset in the Balance Sheet	(457)		(144)
Total Assets, Cash and Non Cash Collateral, Not Offset in the Balance Sheet	(2,931)		(2,658)
Total Assets, Net Amount	117		22
Offsetting Derivative Liabilities [Abstract]
Derivative Liabilities, Fair Value, Gross Amounts	865		262
Derivative Liabilities Subject to Master Netting Arrangements, Gross Amounts Offset in the Balance Sheet	0		0
Derivative Liabilities Subject to Master Netting Arrangements, Net Amount Presented in the Balance Sheet	865		262
Derivative Liabilities, Financial Instruments Not Offset in the Balance Sheet	(457)		(144)
Derivative Liabilities, Cash Collateral Not Offset in the Balance Sheet	(221)		(72)
Derivative Liabilities Subject to Master Netting Arrangements, Net Amount	187		46
Effect of Fair Value Hedges on Results of Operations [Abstract]
Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge	(954)	$ (485)
Net Change In Unrealized Gain (Loss) Recognized In Income Statement On Fair Value Hedging Instruments And On Hedged Item In Fair Value Hedge	0	0
Assets
Offsetting Derivative Assets [Abstract]
Derivative Assets, Fair Value, Gross Amounts	2,016		986
Liabilities
Offsetting Derivative Liabilities [Abstract]
Derivative Liabilities, Fair Value, Gross Amounts	910		303
Designated as Hedging Instrument [Member] | Assets
Offsetting Derivative Assets [Abstract]
Derivative Assets, Fair Value, Gross Amounts	1,645		746
Designated as Hedging Instrument [Member] | Liabilities
Offsetting Derivative Liabilities [Abstract]
Derivative Liabilities, Fair Value, Gross Amounts	465		168
Not Designated as Hedging Instrument [Member]
Derivative Instruments Not Designated as Hedging Instruments [Abstract]
Gains (Losses) Recognized in Income On Derivatives	(191)	189
Not Designated as Hedging Instrument [Member] | Assets
Offsetting Derivative Assets [Abstract]
Derivative Assets, Fair Value, Gross Amounts	371		240
Not Designated as Hedging Instrument [Member] | Liabilities
Offsetting Derivative Liabilities [Abstract]
Derivative Liabilities, Fair Value, Gross Amounts	445		135
Foreign currency contracts
Notional Disclosures [Abstract]
Notional amount	27,039		23,981
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net [Abstract]
Gains (Losses) Recognized in Other Comprehensive Income (Loss) on Derivatives (Effective Portion)	(373)	29
Foreign currency contracts | Designated as Hedging Instrument [Member] | Assets
Offsetting Derivative Assets [Abstract]
Derivative Assets, Fair Value, Gross Amounts	10		56
Foreign currency contracts | Designated as Hedging Instrument [Member] | Liabilities
Offsetting Derivative Liabilities [Abstract]
Derivative Liabilities, Fair Value, Gross Amounts	465		159
Foreign currency contracts | Not Designated as Hedging Instrument [Member] | Interest and other, net [Member]
Derivative Instruments Not Designated as Hedging Instruments [Abstract]
Gains (Losses) Recognized in Income On Derivatives	154	57
Foreign currency contracts | Not Designated as Hedging Instrument [Member] | Assets
Offsetting Derivative Assets [Abstract]
Derivative Assets, Fair Value, Gross Amounts	362		179
Foreign currency contracts | Not Designated as Hedging Instrument [Member] | Liabilities
Offsetting Derivative Liabilities [Abstract]
Derivative Liabilities, Fair Value, Gross Amounts	135		78
Interest rate contracts
Notional Disclosures [Abstract]
Notional amount	13,859		14,302
Effect of Fair Value Hedges on Results of Operations [Abstract]
Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments	954	485
Interest rate contracts | Designated as Hedging Instrument [Member] | Assets
Offsetting Derivative Assets [Abstract]
Derivative Assets, Fair Value, Gross Amounts	1,635		690
Interest rate contracts | Designated as Hedging Instrument [Member] | Liabilities
Offsetting Derivative Liabilities [Abstract]
Derivative Liabilities, Fair Value, Gross Amounts	0		9
Interest rate contracts | Not Designated as Hedging Instrument [Member] | Interest and other, net [Member]
Derivative Instruments Not Designated as Hedging Instruments [Abstract]
Gains (Losses) Recognized in Income On Derivatives	(77)	(14)
Interest rate contracts | Not Designated as Hedging Instrument [Member] | Assets
Offsetting Derivative Assets [Abstract]
Derivative Assets, Fair Value, Gross Amounts	4		11
Interest rate contracts | Not Designated as Hedging Instrument [Member] | Liabilities
Offsetting Derivative Liabilities [Abstract]
Derivative Liabilities, Fair Value, Gross Amounts	120		54
Other
Notional Disclosures [Abstract]
Notional amount	1,726		1,753
Other | Not Designated as Hedging Instrument [Member] | Various [Member]
Derivative Instruments Not Designated as Hedging Instruments [Abstract]
Gains (Losses) Recognized in Income On Derivatives	(268)	$ 146
Other | Not Designated as Hedging Instrument [Member] | Assets
Offsetting Derivative Assets [Abstract]
Derivative Assets, Fair Value, Gross Amounts	5		50
Other | Not Designated as Hedging Instrument [Member] | Liabilities
Offsetting Derivative Liabilities [Abstract]
Derivative Liabilities, Fair Value, Gross Amounts	190		3
Interest Rate Swap | Fair Value Hedging
Derivative Instruments Not Designated as Hedging Instruments [Abstract]
Gains (Losses) Recognized in Income On Derivatives	(1,726)		(781)
Interest Rate Swap | Long-term Debt | Fair Value Hedging
Derivative [Line Items]
Derivative, Amount of Hedged Item	12,000		12,000
Derivative, Fair Value, Net	(13,632)		(12,678)
Derivative Instruments Not Designated as Hedging Instruments [Abstract]
Gains (Losses) Recognized in Income On Derivatives	$ (1,635)		$ (681)

Contingencies (Detail)

Contingencies (Detail) - 1 months ended May 31, 2009 € in Billions, $ in Billions	USD ($)	EUR (€)
EC Fine [Member]
Loss Contingencies [Line Items]
Loss Contingency, Damages Paid Value	$ 1.4	€ 1.1